BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17401015)

  • 1. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
    Li J; Bentzen SM; Renschler M; Mehta MP
    J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
    Li J; Bentzen SM; Li J; Renschler M; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone.
    Chang EL; Wefel JS; Maor MH; Hassenbusch SJ; Mahajan A; Lang FF; Woo SY; Mathews LA; Allen PK; Shiu AS; Meyers CA
    Neurosurgery; 2007 Feb; 60(2):277-83; discussion 283-4. PubMed ID: 17290178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
    Mehta MP; Rodrigus P; Terhaard CH; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R; Schultz C; Timmerman R; Curran W; Smith J; Phan SC; Miller RA; Renschler MF
    J Clin Oncol; 2003 Jul; 21(13):2529-36. PubMed ID: 12829672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of whole brain re-irradiation for brain metastases--single centre experience.
    Sadikov E; Bezjak A; Yi QL; Wells W; Dawson L; Millar BA; Laperriere N
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):532-8. PubMed ID: 17662582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
    Scott C; Suh J; Stea B; Nabid A; Hackman J
    Am J Clin Oncol; 2007 Dec; 30(6):580-7. PubMed ID: 18091051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
    Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D; Dunst J; Schild SE
    Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory function before and after whole brain radiotherapy in patients with and without brain metastases.
    Welzel G; Fleckenstein K; Schaefer J; Hermann B; Kraus-Tiefenbacher U; Mai SK; Wenz F
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1311-8. PubMed ID: 18448270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed.
    Brown PD; Asher AL; Farace E
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1305-9. PubMed ID: 18234426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
    Meyers CA; Smith JA; Bezjak A; Mehta MP; Liebmann J; Illidge T; Kunkler I; Caudrelier JM; Eisenberg PD; Meerwaldt J; Siemers R; Carrie C; Gaspar LE; Curran W; Phan SC; Miller RA; Renschler MF
    J Clin Oncol; 2004 Jan; 22(1):157-65. PubMed ID: 14701778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
    Wong J; Hird A; Zhang L; Tsao M; Sinclair E; Barnes E; Danjoux C; Chow E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1125-31. PubMed ID: 19231099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.
    Stea B; Suh JH; Boyd AP; Cagnoni PJ; Shaw E;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1023-30. PubMed ID: 16446056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year survivors of brain metastases: a single-institution report of 32 patients.
    Chao ST; Barnett GH; Liu SW; Reuther AM; Toms SA; Vogelbaum MA; Videtic GM; Suh JH
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):801-9. PubMed ID: 16904847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
    Grosshans DR; Meyers CA; Allen PK; Davenport SD; Komaki R
    Cancer; 2008 Feb; 112(3):589-95. PubMed ID: 18098269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.